Olga Flamini (Borodovitsyna), MD, PhD

Olga Flamini (Borodovitsyna), MD, PhD has a diverse work experience in the medical field. Olga is currently serving as the Medical Director at Myrtelle since December 2022. Prior to this, they held the position of Director, Clinical and Regulatory Program Operations at the same company from August 2021 to December 2022. Before joining Myrtelle, Olga worked as a Clinical Trial Manager at Myrtelle from May 2021 to August 2021.

From 2019 to 2021, Olga served as a Clinical Project Manager at LLC CureRareDisease. Olga also worked as an Ophthalmologist at "Family Doctor" from May 2015 to June 2016, and at Sphera Clinic from May 2015 to June 2016, where they specialized in diagnosing and treating various ophthalmological conditions, including performing retinal laser surgeries.

Olga's earlier experience includes working as an Ophthalmologist at Medical Unit 55 from October 2014 to June 2015. Olga also served as an Ophthalmology Resident at the Federal State Institute named after Fedorov from September 2012 to September 2014. Olga began their career in research as a Research Assistant at Moscow State University of Medicine and Dentistry, where they focused on macrophage reprogramming as a treatment strategy for different diseases from 2009 to 2013.

In addition, Olga gained hands-on research experience as a Summer Research Student at the University of North Texas in 2011, studying the interaction between signaling pathways involved in the development of glaucoma and glucocorticoid signaling pathways in trabecular meshwork cells.

Overall, Olga Flamini (Borodovitsyna), MD, PhD has a strong background in clinical management, ophthalmology, and research in the medical field.

Olga Flamini (Borodovitsyna), MD, PhD completed their education in a chronological order. From 2006 to 2012, they attended Moscow State University of Medicine and Dentistry, where they earned their Doctor of Medicine (M.D.) degree with honors, equivalent to summa cum laude. Their field of study during this time is not specified.

Later, from 2016 to 2021, Olga pursued a Doctor of Philosophy (PhD) in Neuroscience at Rowan University. This course of study indicates their interest in the field of neuroscience.

Additionally, Olga Flamini has obtained several certifications. In July 2014, they acquired the ECFMG certificate from ECFMG. In December 2019, they completed the GCP course Group 2: Biomedical and Basic Research - Biomedical and Basic, offered by CITI Program, a division of BRANY. Furthermore, in May 2020, they obtained a certification in Data Management for Clinical Research from Coursera. Most recently, in March 2022, Olga Flamini completed a Paediatric Drug Development & Clinical Trials training from Symmetric Training.

No further assumptions or information beyond the provided education history and certifications can be made about Olga Flamini (Borodovitsyna), MD, PhD.